Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,397 across all filing types
Latest filing 2025-02-26 Investor Presentation
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
Conference Call FY 2024, Fresenius
Investor Presentation Classification · 100% confidence The document is a detailed slide deck titled 'FutureFresenius: REJUVENATE for next level performance' presented during the 'Full Year and Q4 2024 results' conference call. It contains financial highlights, strategy updates, performance metrics, and forward-looking guidance. As it is a comprehensive presentation deck used for investor communication regarding financial results and strategy, it is classified as an Investor Presentation.
2025-02-26 English
Compensation Report 2024
Remuneration Information Classification · 95% confidence The document is a detailed 'Compensation Report' for Fresenius SE & Co. KGaA for the fiscal year 2024. It outlines the compensation system, governance, and performance targets for the Management Board. While it is part of the broader Annual Report, the specific content provided is the 'Compensation Report' section, which is categorized under 'Remuneration Information' (DEF 14A) in the provided schema, as it details executive and director compensation.
2025-02-25 English
Declaration of Voting Results & Voting Rights Announcements 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting rights Announcements' and contains sections like 'Notification of Major Holdings', detailing the acquisition/disposal of shares and instruments by BlackRock, Inc. in Fresenius SE & Co. KGaA. It specifies the date the threshold was crossed (14 Feb 2025) and provides detailed breakdowns of voting rights percentages. This content directly matches the definition of a Major Shareholding Notification, which is classified under the code MRQ in the provided schema.
2025-02-20 English
Declaration of Voting Results & Voting Rights Announcements 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting rights Announcements' and contains sections like 'Notification of Major Holdings', 'Details of issuer', 'Reason for notification', and 'Total positions' detailing changes in voting rights percentages (e.g., 'New | 4.88 %'). This structure is characteristic of mandatory regulatory filings concerning changes in significant share ownership thresholds. Based on the provided definitions, this aligns perfectly with the 'Major Shareholding Notification' category (Code: MRQ). Although it mentions 'Voting rights Announcements' in the header, the content is specifically about holding changes, which maps to MRQ better than DVA (Declaration of Voting Results).
2025-02-19 English
Declaration of Voting Results & Voting Rights Announcements 2025
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled 'Voting rights Announcements' and contains sections detailing the 'Notification of Major Holdings' by BlackRock, Inc. in Fresenius SE & Co. KGaA. It specifies the date the threshold was crossed (13 Feb 2025) and details the percentage of voting rights held (5.02%). This content directly corresponds to the definition of a Major Shareholding Notification, which is classified under the code MRQ (Major Shareholding Notification). Although the header mentions 'Voting rights Announcements', the core content is the change in major shareholding.
2025-02-19 English
Declaration of Conformity of Fresenius SE & Co. KGaA as of December 2024
Governance Information Classification · 100% confidence The document is a 'Declaration of Conformity' regarding the German Corporate Governance Code, issued pursuant to Section 161 of the German Stock Corporation Act. It details the company's adherence to governance recommendations and explains specific deviations. This content falls squarely under the definition of Governance Information (CGR), which covers internal rules, board structure, and governance practices.
2024-12-01 English

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.